- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Paraoxonase.
Displaying page 1 of 1.
EudraCT Number: 2010-018531-17 | Sponsor Protocol Number: TRED012010 | Start Date*: 2010-06-25 |
Sponsor Name:Central Manchester University Hospitals NHS Foundation Trust | ||
Full Title: Effect of Tredaptive on serum lipoproteins, lipoproteins metabolism, oxidative stress and HDL antioxidant function. | ||
Medical condition: Hypercholesterolaemia. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006889-42 | Sponsor Protocol Number: FCM 01–FARM01 | Start Date*: 2007-07-18 | |||||||||||
Sponsor Name:Faculdade de Ciências Médicas – Universidade Nova de Lisboa | |||||||||||||
Full Title: Exploratory, double blind placebo controlled, randomized, single cross-over study to evaluate the potential anti-oxidant action of Niaspan | |||||||||||||
Medical condition: Hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002523-26 | Sponsor Protocol Number: WI88341 | Start Date*: 2016-03-08 | |||||||||||
Sponsor Name:Arthritis Alapítvány | |||||||||||||
Full Title: Effects of JAK inhibition on rheumatoid arthritis-related comorbidities: link between bone and vascular effects (investigator-initiated grant proposal) | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005567-33 | Sponsor Protocol Number: MEIN/14/FEB-PWV/001 | Start Date*: 2015-09-11 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A. | |||||||||||||
Full Title: The Effect of Intensive Urate Lowering Therapy (ULT) with Febuxostat in Comparison with Allopurinol on Cardiovascular Risk in Patients with Gout Using Surrogate Markers: a Randomized, Controlled Tr... | |||||||||||||
Medical condition: Gout | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) PL (Completed) HR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
